24
March
2014
March
2014
Commercial policies of pharmaceutical companies and medical device manufacturers: new lessons for market players
VEGAS LEX_Коммерческие политики производителей лекарственных препаратов.Новые уроки для бинеса
Download file| File added | 12.08.2015 |
| Presentation | .pdf (398 Кб) |
VEGAS LEX_Legal Alert_(eng)_4_03_2014
Download file| File added | 22.09.2015 |
| Presentation | .pdf (432 Кб) |
Federal Antimonopoly Service (FAS) and Russian court practice in addressing unreasonable refusals to enter into a supply agreement continues to develop. Several new cases considered by the FAS and the courts at the end of 2013/beginning of 2014 have enabled the identification of new trends in legal implementation policies.
We would like to offer you an analytical survey of VEGAS LEX on COMMERCIAL POLICIES OF PHARMACEUTICALS COMPANIES AND MEDICAL DEVICE: NEW LESSONS FOR MARKET PLAYERS.
In our latest issue:
- Who is at risk?
- How is market share determined?
- What exactly may reveal a restraint on competition?
- What to do next?